IRVING, Texas, Oct. 6, 2021 /PRNewswire/ Caris Life Sciences®, a molecular science company developing and delivering technologies to revolutionize healthcare, announced today the.
Seven companies shaking up Dallas-Fort Worth s emerging biotech landscape dallasnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dallasnews.com Daily Mail and Mail on Sunday newspapers.
IRVING, Texas, May 11, 2021 /PRNewswire/ Caris Life Sciences
®, a leading innovator in molecular science and artificial intelligence (AI) focused on fulfilling the promise of precision medicine, announced an $830 million growth equity round at a post-money valuation of $7.83 billion. With this investment, Caris has raised approximately $1.3 billion in external financing since 2018. This financing represents one of the largest capital raises in precision medicine and includes a diverse syndicate of leading investors.
The round was led by Sixth Street, a leading global investment firm making its third investment in Caris since 2018. Funds and accounts advised by T. Rowe Price Associates, Inc., Silver Lake, Fidelity Management & Research Company LLC, and Coatue were significant participants in the round. Additional investors included Columbia Threadneedle Investments, Canada Pension Plan Investment Board, Millennium Management, Neuberger Berman Funds, Highland Capital Management,
Caris Life Sciences’ massive new capital raise gives it a valuation of nearly $8 billion
The Irving-based precision medicine company is getting a major boost from an $830 million equity round.
Caris Life Sciences is headquartered in Irving.(Courtesy of Caris Life Sciences)
4:28 PM on May 11, 2021 CDT
The Irving-based precision medicine pioneer Caris Life Sciences is hauling in a massive investment that places a nearly $8 billion valuation on the 13-year-old company.
The $830 million equity round includes some of the biggest names in investment circles, including Sixth Street and funds associated with T. Rowe Price, Fidelity, Silver Lake and Coatue. A dozen other investors also took part.
Caris Life Sciences Raises $830M in Growth Equity Funding
Caris Life Sciences, an Irving, Texas-based innovator in molecular science and artificial intelligence (AI) focused on fulfilling the promise of precision medicine, raised $830m in growth equity funding at a post-money valuation of $7.83 billion.
The round was led by Sixth Street, with participation from funds and accounts advised by T. Rowe Price Associates, Inc., Silver Lake, Fidelity Management & Research Company LLC, Coatue, Columbia Threadneedle Investments, Canada Pension Plan Investment Board, Millennium Management, Neuberger Berman Funds, Highland Capital Management, Rock Springs Capital, OrbiMed, ClearBridge Investments, Tudor Investment Corporation, Eaton Vance Equity (Morgan Stanley), Pura Vida Investments and First Light Asset Management.